Archford Capital Strategies’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-270
| Closed | -$17K | – | 317 |
|
|
2019
Q2 | $17K | Hold |
270
| – | – | 0.01% | 365 |
|
|
2019
Q1 | $17K | Hold |
270
| – | – | 0.01% | 353 |
|
|
2018
Q4 | $14K | Sell |
270
-570
| -68% | -$29.6K | 0.01% | 351 |
|
|
2018
Q3 | $49K | Hold |
840
| – | – | 0.02% | 297 |
|
|
2018
Q2 | $41K | Buy |
840
+270
| +47% | +$13.2K | 0.01% | 307 |
|
|
2018
Q1 | $21K | Buy |
+570
| New | +$21K | 0.01% | 276 |
|
|
2017
Q2 | – | Sell |
-570
| Closed | -$18K | – | 329 |
|
|
2017
Q1 | $18K | Hold |
570
| – | – | 0.01% | 381 |
|
|
2016
Q4 | $17K | Hold |
570
| – | – | 0.01% | 336 |
|
|
2016
Q3 | $22K | Buy |
+570
| New | +$22K | 0.01% | 318 |
|
|
2016
Q1 | – | Sell |
-570
| Closed | -$16K | – | 310 |
|
|
2015
Q4 | $16K | Hold |
570
| – | – | 0.01% | 394 |
|
|
2015
Q3 | $14K | Hold |
570
| – | – | 0.01% | 305 |
|
|
2015
Q2 | $14K | Hold |
570
| – | – | 0.01% | 298 |
|
|
2015
Q1 | $13.5K | Hold |
570
| – | – | 0.01% | 314 |
|
|
2014
Q4 | $12K | Hold |
570
| – | – | 0.01% | 328 |
|
|
2014
Q3 | $10K | Hold |
570
| – | – | 0.01% | 345 |
|
|
2014
Q2 | $8.15K | Hold |
570
| – | – | 0.01% | 438 |
|
|
2014
Q1 | $7.05K | Buy |
+570
| New | +$7.05K | 0.01% | 487 |
|